CKD Bio Corp. (KRX:063160)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,000
+150 (0.66%)
At close: Jun 5, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY TTM FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Drug Substance
133.93B
Log In
Log In
Log In
Log In
Upgrade
Drug Substance Growth
7.07%
Log In
Log In
Log In
Log In
Upgrade
Probiotics
19.06B
Log In
Log In
Log In
Log In
Upgrade
Probiotics Growth
-23.72%
Log In
Log In
Log In
Log In
Upgrade
Botulinum Toxin
7.36B
Log In
Log In
Log In
Log In
Upgrade
Botulinum Toxin Growth
23.32%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Ingredients and Health Functional Foods
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Ingredients and Health Functional Foods Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY TTM FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Europe
56.28B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
50.62%
Log In
Log In
Log In
Log In
Upgrade
Asia
37.64B
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-22.58%
Log In
Log In
Log In
Log In
Upgrade
South Korea
37.18B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-19.04%
Log In
Log In
Log In
Log In
Upgrade
Middle East
12.90B
Log In
Log In
Log In
Log In
Upgrade
Middle East Growth
89.94%
Log In
Log In
Log In
Log In
Upgrade
Other
16.35B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-5.71%
Log In
Log In
Log In
Log In
Upgrade